The big news for Alcon was the long-awaited consummation of its prolonged merger with Novartis, which both companies’ shareholders approved in early April 2011. As a Novartis division, the company contributed $9.96 billion to the top line last year.
Home » Alcon
Alcon
More recent news
- Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
- PharmaSens, SiBionics collab on all-in-one insulin patch pump
- Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
- Anaconda Biomed wins CE mark for funnel catheter
- FDA approves Neuspera neuromod for urinary incontinence
